Endovascular reperfusion strategy for infra-popliteal chronic limb threatening ischaemia

Affiliations

¹ Department of Cardiology, Franciscan Health, Lafayette, IN 47905, USA. Electronic address: akalra@alumni.harvard.edu.
² Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA.

Comment

Ankur Kalra et al. Lancet. 2023.

. 2023 May 27;401(10390):1749-1750.

doi: 10.1016/S0140-6736(23)00632-3. Epub 2023 Apr 25.

¹ Department of Cardiology, Franciscan Health, Lafayette, IN 47905, USA. Electronic address: akalra@alumni.harvard.edu.
² Department of Internal Medicine, Cleveland Clinic Akron General, Akron, OH, USA.

No abstract available

Comment on

Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy.
Bradbury AW, Adam DJ, Bell J, Forbes JF, Fowkes FG, Gillespie I, Ruckley CV, Raab GM; BASIL trial Participants. Bradbury AW, et al. J Vasc Surg. 2010 May;51(5 Suppl):5S-17S. doi: 10.1016/j.jvs.2010.01.073. J Vasc Surg. 2010. PMID: 20435258 Clinical Trial.